ALLURION TECHNOLOGIES, INC.

Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.

ALUR | NYSE

Overview

Corporate Details

ISIN(s):: US02008G1022
LEI:
Country:: United States of America
Address:: 11 HURON DR STE 200, 1760 NATICK
Website:: https://www.allurion.com/en
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Allurion Technologies, Inc. is a medical technology company dedicated to ending obesity. The company develops and markets the Allurion Program, a comprehensive weight-loss platform centered around the world's first and only swallowable, procedure-less gastric balloon. The program integrates the medical device with a full digital ecosystem, including the Allurion App, a Connected Scale, and an AI-powered coach, to provide real-time tracking and support. This is combined with professional nutritional coaching and medical supervision over a minimum six-month period. The platform is designed to help patients achieve and maintain metabolically healthy weight loss without surgery or endoscopy, and is available through a global network of partner clinics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ALLURION TECHNOLOGIES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLURION TECHNOLOGIES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ALLURION TECHNOLOGIES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TISSUE REGENIX GROUP PLC Develops regenerative biological products for orthopaedic and dental markets.	United Kingdom	TRX
Tivic Health Systems, Inc. Develops bioelectronic devices for sinus relief and therapies for radiation countermeasures.	United States of America	TIVC
TransMedics Group, Inc. FDA-approved warm perfusion tech and services to increase organ transplant viability and volume.	United States of America	TMDX
T&R Biofab Co., Ltd Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.	South Korea	246710
TREACE MEDICAL CONCEPTS, INC. Develops patented systems for the surgical correction of bunion and midfoot deformities.	United States of America	TMCI
TRINITY BIOTECH PLC Develops and markets clinical diagnostic test kits and biosensors for labs and point-of-care.	United States of America	TRIB
TriSalus Life Sciences, Inc. Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.	United States of America	TLSI
TruSpine Technologies Plc Developing disruptive, pre-approval technologies for the spinal stabilization market.	United Kingdom	TSP
Twist Bioscience Corp Offers scalable DNA synthesis on silicon for research, drug discovery, and diagnostics.	United States of America	TWST
UFP TECHNOLOGIES INC Designs & manufactures custom products from advanced materials for MedTech, aerospace & auto markets.	United States of America	UFPT